Protalix Biotherapeutics Inc (PLX)
R&D Expense Growth
-19.81%
Quarterly · Period ending:
PLX R&D Expense Growth
Latest reported-19.81%period ending
Latest reported-19.81%period ending
PLX Quarterly R&D Growth (QoQ) (0.00% → -19.81%)
Latest values, visible window
High-resolution chart · PNG
PLX r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |